SERPINA1 and HIV-1 infection: Activation of acute phase reactants may represent a very early line of anti-viral defense in HIV-1 infection, since A-SAA, AAT and a C-terminal peptide derived from AAT (referred to as VIRIP) were each shown to exert anti-viral activity in vitro[10], [19], [25], [26] (Fig. 6A,B).